Utama › Kanser Paru-paru Bukan Sel Kecil › Illinois › Cicero
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Cicero, IL
24 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Cicero (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Mengambil pesertaFasa 1/2
- Hope And Healing Cancer Services /ID# 276223, Hinsdale · 10 mi jauh
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
- Endeavor Health, Elmhurst · 10 mi jauh
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
Mengambil pesertaFasa 2
- Hope and Healing Clinical Research, Hinsdale · 10 mi jauh
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Mengambil pesertaFasa 3
- Research Site, Hinsdale · 10 mi jauh
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Mengambil pesertaFasa 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauh
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 3
- Research Site, Hinsdale · 10 mi jauh
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
Mengambil pesertaFasa 2/3
- Loyola University Medical Center, Maywood · 5 mi jauh
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauh
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Mengambil pesertaFasa 3
- Research Site, Hinsdale · 10 mi jauh
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Research Site, Hinsdale · 10 mi jauh
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Mengambil pesertaFasa 3
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Mengambil pesertaFasa 3
- Elmhurst Hospital Nancy Knowles Cancer Center, Elmhurst · 10 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 mi jauh
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
- dan 2 lagi
MYLUNG Consortium Part 3: Observational Study
Mengambil pesertaKajian pemerhatian
- Affiliated Oncologists, LLC, Chicago Ridge · 10 mi jauh
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
- dan 3 lagi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Loyola University Medical Center, Maywood · 5 mi jauh
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
- dan 2 lagi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Edward Hines Jr VA Hospital, Hines · 4 mi jauh
- Loyola University Medical Center, Maywood · 5 mi jauh
- Northwestern Medicine Oak Brook, Oak Brook · 9 mi jauh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- Advocate Christ Medical Center, Oak Lawn · 9 mi jauh
- Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 mi jauh
- Advocate High Tech Medical Park, Palos Heights · 12 mi jauh
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Mengambil peserta
- Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 mi jauh
GEMINI-NSCLC: NSCLC Biomarker Study
Mengambil pesertaKajian pemerhatian
- Hope and Healing Cancer Services, Hinsdale · 10 mi jauh
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Cicero
- Kanser Paru-paru17 kajian
- Kanser Prostat14 kajian
- Kanser (semua jenis)13 kajian
- Kanser Payudara11 kajian
- Leukemia Mieloid Akut11 kajian
- Kanser Kolorektal10 kajian
- Kanser Pundi Kencing8 kajian
- Melanoma7 kajian
- Penyakit Kardiovaskular7 kajian
- Kanser Metastatik7 kajian
- Mieloma Pelbagai6 kajian
- Limfoma Burkitt6 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.